Skip to main content
. Author manuscript; available in PMC: 2024 Jul 3.
Published in final edited form as: Bone Marrow Transplant. 2024 Feb 21;59(5):680–687. doi: 10.1038/s41409-024-02245-y

Figure 3. Contribution of the aGVHD component to the global severity score of ocGVHD.

Figure 3.

Left bar: Proportion of patients with moderate ocGVHD at presentation who would have been down-graded to mild cGVHD if the aGVHD contributions were omitted (31%). Middle bar: Proportion of patients with severe ocGVHD at presentation who would have been down-graded to mild cGVHD if the aGVHD contributions were omitted (44%). Right bar: Proportion of patients with severe ocGVHD at presentation who would have been down-graded to moderate cGVHD if the aGVHD contributions were omitted (33%).